Home
Home About Us Our Technology News + Media Investor Relations Contact Us
 
Investor Info
SEC Filings

XBRL Filings
Governance Documents
 

Investor Relations



CytoSorbents Investor Materials

14th Annual Needham Healthcare Conference
Presentation                        Audiocast

CytoSorbents Year End 2014 Conference Call - March 31, 2015
Official Transcript                Presentation                Webcast

CytoSorbents Investor Presentation - February 2015

CytoSorbents Shareholder Update Letter - November 2014

CytoSorbents Q3 2014 Conference Call - November 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q2 2014 Conference Call  -  August 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q1 2014 Conference Call    -    May 14, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Fiscal 2013 Conference Call - March 31, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q3 2013 Conference Call - November 6, 2013
Official Transcript                Presentation                Webcast

CytoSorbents Executive Summary - November 2014

2014 Rodman & Renshaw Annual Global Investment Conference - September 3, 2014

The Wall Street Transcript Interview - August 2014

CytoSorbents 2013 Shareholder Letter - January 2014

CytoSorbents Marketing Material

HemoDefend Product Overview Brochure - 2013

CytoSorbents Clinical and Scientific Data

Recent published case reports and studies on CytoSorb. Click on hyperlinked titles to download articles

CytoSorbents Analyst Coverage

Zacks - CTSO: Short-Term Hiccup. Long-Term Outlook Remains Intact - April 2015

Zacks - CTSO: FDA Greenlights U.S. Cardiac Surgery Study - Feb 2015

Zacks - CTSO: Fresenius Adds More than Just Marketing Muscle - Dec 2014

Zacks - CTSO: Data Registry, Other Developments Bode Well for Increased Adoption - Nov 2014

Zacks - CTSO: Record Product Sales, Again. Data Supports Cardiac Surgery - August 2014

Zacks - CTSO: Record Product Sales. MERS Opportunity Is Promising - May 2014

Zacks - CTSO: Record Sales in Q4 But Even Bigger Plans for 2014 - April 2014

Zacks - CTSO: Product Sales Jump, Momentum Continues - November 2013

Zacks - CTSO: Tiny Med-Tech With Huge Potential - June 2013

Zacks Small Cap Research Initiation Report Link - June 2012

Brean Murray Research Reports
Email: avogel@cytosorbents.com

H.C. Wainwright Research Reports
Email: avogel@cytosorbents.com

Merriman Research Reports
Email: avogel@cytosorbents.com


CytoSorbents Media

Medical Device Daily - CytoSorb Cardiac Trial IDE Submitted - Dec 2014

Fierce Medical Devices - Fresenius and CytoSorbents Partner - Dec 2014

Fierce Drug Delivery - CytoSorbents Uplists to NASDAQ - Dec 2014

Prince William Recognizes CytoSorbents - Dec 2014

South Brunswick Post U.S. Representative Rush Holt Visit - Jan 2014

Biotech product geared toward reducing deaths in the ICU - Jan 2014

U.S.1 News Feature - July 2013

Frost & Sullivan Report - June 2013

Wall St. Analyst Interview with Dr. Phillip Chan - May 2013

MedCity News Report - May 2013

MedGadget Interview with Dr. Chan - April 2013

Medical Device Daily Cover Story - December 2012

MoneyTV Interview with Dr. Chan - August 2012

OneMedPlace 2012 Interview with Dr. Phillip Chan

For investor relations matters or questions please contact:
avogel@cytosorbents.com

CytoSorbents Medical Inc. is a wholly owned subsidary of CytoSorbents Corporation

 

 
Home | Career Opportunities | Contact Us
© 2014 CytoSorbents Corporation All Rights Reserved